Correction: Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults (New England Journal of Medicine (2017) 377 (1858-1867) DOI: 10.1056/NEJMoa1707572);Age of red cells for transfusion and outcomes in critically ill adults

New England Journal of Medicine

Volumn 377, Issue 19, 2017, Pages 1858-1867

  Cooper, D James ^a,b   McQuilten, Zoe K ^a,c   Nichol, Alistair ^a,b,h   Ady, Bridget ^a   Aubron, Cecile ^a,i   Bailey, Michael ^a   Bellomo, Rinaldo ^a,d,e   Gantner, Dashiell ^a,b   Irving, David O ^f   Kaukonen, Kirsi Maija ^a,j   McArthur, Colin ^k,l   Murray, Lynne ^a   Pettila, Ville ^j   French, Craig ^a,e,g  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c SOUTHERN HEALTH   (Australia)

^d AUSTIN HOSPITAL   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^g WESTERN HEALTH   (Australia)

^h ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

ⁱ BREST UNIVERSITY HOSPITAL   (France)

^j UNIVERSITY OF HELSINKI   (Finland)

^k MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^l AUCKLAND CITY HOSPITAL   (New Zealand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION REACTION; BLOODSTREAM INFECTION; CELL AGING; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DOUBLE BLIND PROCEDURE; ERYTHROCYTE; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME; ALLOTRANSPLANTATION; BLOOD STORAGE; CLINICAL TRIAL; COMPARATIVE STUDY; CRITICAL ILLNESS; INTENTION TO TREAT ANALYSIS; KAPLAN MEIER METHOD; MIDDLE AGED; TIME FACTOR;

ADULT; BLOOD PRESERVATION; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 85033387005     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMx180024     Document Type: Erratum

References (22)

1. Westbrook A, Pettilä V, Nichol A, et al. Transfusion practice and guidelines in Australian and New Zealand intensive care units. Intensive Care Med 2010; 36: 1138-46.
2. Walsh TS, Garrioch M, Maciver C, et al. Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion 2004; 44: 1405-11.
3. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: anemia and blood transfusion in the critically ill - current clinical practice in the United States. Crit Care Med 2004; 32: 39-52.
4. Sparrow RL. Time to revisit red blood cell additive solutions and storage conditions: a role for "omics" analyses. Blood Transfus 2012; 10: Suppl 2: s7-s11.
5. Flegel WA, Natanson C, Klein HG. Does prolonged storage of red blood cells cause harm?. Br J Haematol 2014; 165: 3-16.
6. Pettilä V, Westbrook AJ, Nichol AD, et al. Age of red blood cells and mortality in the critically ill. Crit Care 2011; 15: R116.
7. Wang D, Sun J, Solomon SB, Klein HG, Natanson C. Transfusion of older stored blood and risk of death: a metaanalysis. Transfusion 2012; 52: 1184-95.
8. Stanger SH, Yates N, Wilding R, Cotton S. Blood inventory management: hospital best practice. Transfus Med Rev 2012; 26: 153-63.
9. Janz DR, Zhao Z, Koyama T, et al. Longer storage duration of red blood cells is associated with an increased risk of acute lung injury in patients with sepsis. Ann Intensive Care 2013; 3: 33.
10. Vlaar AP, Hofstra JJ, Levi M, et al. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a "two-hit" in vivo syngeneic transfusion model. Anesthesiology 2010; 113: 92-103.
11. Lacroix J, Hébert PC, Fergusson DA, et al. Age of transfused blood in critically ill adults. N Engl J Med 2015; 372: 1410-8.
12. Heddle NM, Cook RJ, Arnold DM, et al. Effect of short-term vs. long-term blood storage on mortality after transfusion. N Engl J Med 2016; 375: 1937-45.
13. Chai-Adisaksopha C, Alexander PE, Guyatt G, et al. Mortality outcomes in patients transfused with fresher versus older red blood cells: a meta-analysis. Vox Sang 2017; 112: 268-78.
14. Kaukonen KM, Bailey M, Ady B, et al. A randomised controlled trial of standard transfusion versus fresher red blood cell use in intensive care (TRANSFUSE): protocol and statistical analysis plan. Crit Care Resusc 2014; 16: 255-61.
15. Aubron C, Syres G, Nichol A, et al. A pilot feasibility trial of allocation of freshest available red blood cells versus standard care in critically ill patients. Transfusion 2012; 52: 1196-202.
16. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22: 707-10.
17. Alexander PE, Barty R, Fei Y, et al. Transfusion of fresher vs older red blood cells in hospitalized patients: a systematic review and meta-analysis. Blood 2016; 127: 400-10.
18. Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, et al. Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children with severe anemia: the TOTAL randomized clinical trial. JAMA 2015; 314: 2514-23.
19. Bakkour S, Acker JP, Chafets DM, et al. Manufacturing method affects mitochondrial DNA release and extracellular vesicle composition in stored red blood cells. Vox Sang 2016; 111: 22-32.
20. Boudreau LH, Duchez AC, Cloutier N, et al. Platelets release mitochondria serving as substrate for bactericidal group IIAsecreted phospholipase A2 to promote inflammation. Blood 2014; 124: 2173-83.
21. Yasui K, Matsuyama N, Kuroishi A, Tani Y, Furuta RA, Hirayama F. Mitochondrial damage-associated molecular patterns as potential proinflammatory mediators in post-platelet transfusion adverse effects. Transfusion 2016; 56: 1201-12.
22. Simmons JD, Lee YL, Pastukh VM, et al. Potential contribution of mitochondrial DNA damage associated molecular patterns in transfusion products to the development of acute respiratory distress syndrome after multiple transfusions. J Trauma Acute Care Surg 2017; 82: 1023-9.